Related Experiment Video
Updated: Aug 17, 2025

Isolation of Next-Generation Gene Therapy Vectors through Engineering, Barcoding, and Screening of Adeno-Associated Virus AAV Capsid Variants
Published on: October 18, 2022
Public support for global vaccine sharing in the COVID-19 pandemic: Evidence from Germany
Ferdinand Geissler1, Felix Hartmann1, Macartan Humphreys2,3
1Humboldt-Universität zu Berlin, Berlin, Germany.
Abstract:
By September 2021 an estimated 32% of the global population was fully vaccinated for COVID-19 but the global distribution of vaccines was extremely unequal, with 72% or more vaccinated in the ten countries with the highest vaccination rates and less than 2% in the ten countries with the lowest vaccination rates. Given that governments need to secure public support for investments in global vaccine sharing, it is important to understand the levels and drivers of public support for international vaccine solidarity. Using a factorial experiment administered to more than 10,000 online survey respondents in Germany in 2021, we demonstrate that the majority of German citizens are against global inequalities in vaccine distribution. Respondents are supportive of substantive funding amounts, on the order of the most generous contributions provided to date, though still below amounts that are likely needed for a successful global campaign. Public preferences appear largely to be driven by intrinsic concern for the welfare of global populations though are in part explained by material considerations-particularly risks of continued health threats from a failure to vaccinate globally. Strategic considerations are of more limited importance in shaping public opinion; in particular we see no evidence for free riding on contributions by other states. Finally, drawing on an additional survey experiment, we show that there is scope to use information campaigns highlighting international health externalities to augment public support for global campaigns.
More Related Videos
Related Concept Videos
Vaccinations
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Microorganisms in Medicine and Therapeutics
International Nursing Organizations II
The WHO provides expert team support, including funding, vaccines, testing, and treatment tools at the country level to fight...
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Principles of Disease Surveillance

